Systemic Autoimmune Disease Among Adults Exposed to the September 11, 2001 Terrorist Attack.
Journal
Arthritis & rheumatology (Hoboken, N.J.)
ISSN: 2326-5205
Titre abrégé: Arthritis Rheumatol
Pays: United States
ID NLM: 101623795
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
received:
14
03
2019
accepted:
19
11
2019
pubmed:
26
11
2019
medline:
17
7
2020
entrez:
26
11
2019
Statut:
ppublish
Résumé
Autoimmune disease is an emerging condition among persons exposed to the September 11, 2001 attack on the World Trade Center (WTC). Components of the dust cloud resulting from the collapse of the WTC have been associated with development of a systemic autoimmune disease, as has posttraumatic stress disorder (PTSD). We undertook this study to determine whether dust exposure and PTSD were associated with an increased risk of systemic autoimmune disease in a 9/11-exposed cohort. Among 43,133 WTC Health Registry enrollees, 2,786 self-reported having a post-9/11 systemic autoimmune disease. We obtained informed consent to review medical records to validate systemic autoimmune disease diagnoses for 1,041 enrollees. Diagnoses of systemic autoimmune diseases were confirmed by classification criteria, rheumatologist diagnosis, or having been prescribed systemic autoimmune disease medication. Controls were enrollees who denied having an autoimmune disease diagnosis (n = 37,017). We used multivariable log-binomial regression to examine the association between multiple 9/11 exposures and risk of post-9/11 systemic autoimmune disease, stratifying by responders (rescue, recovery, and clean-up workers) and community members (e.g., residents, area workers). We identified 118 persons with systemic autoimmune disease. Rheumatoid arthritis was most frequent (n = 71), followed by Sjӧgren's syndrome (n = 22), systemic lupus erythematosus (n = 20), myositis (n = 9), mixed connective tissue disease (n = 7), and scleroderma (n = 4). Among 9/11 responders, those with intense dust cloud exposure had almost twice the risk of systemic autoimmune disease (adjusted risk ratio 1.86 [95% confidence interval 1.02-3.40]). Community members with PTSD had a nearly 3-fold increased risk of systemic autoimmune disease. Intense dust cloud exposure among responders and PTSD among community members were associated with a statistically significant increased risk of new-onset systemic autoimmune disease. Clinicians treating 9/11 survivors should be aware of the potential increased risk of systemic autoimmune disease in this population.
Identifiants
pubmed: 31762219
doi: 10.1002/art.41175
pmc: PMC7216890
doi:
Substances chimiques
Dust
0
Types de publication
Journal Article
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
849-859Subventions
Organisme : NIOSH CDC HHS
ID : U50 OH009739
Pays : United States
Informations de copyright
© 2019 The Authors. Arthritis & Rheumatology published by Wiley Periodicals, Inc. on behalf of American College of Rheumatology.
Références
Occup Environ Med. 2002 Aug;59(8):545-9
pubmed: 12151611
Mayo Clin Proc. 2016 Jan;91(1):23-32
pubmed: 26682920
Environ Health Perspect. 2004 May;112(6):731-9
pubmed: 15121517
Environ Health Perspect. 2006 Aug;114(8):1243-7
pubmed: 16882533
Curr Opin Rheumatol. 2016 Sep;28(5):497-505
pubmed: 27428889
Environ Health Perspect. 2014 Oct;122(10):1075-80
pubmed: 24905961
N Engl J Med. 1975 Feb 13;292(7):344-7
pubmed: 1090839
Environ Health Perspect. 2002 Jul;110(7):703-14
pubmed: 12117648
Stat Med. 2007 Apr 15;26(8):1688-701
pubmed: 17285683
Environ Res. 2015 Jul;140:474-8
pubmed: 25988990
J Rheumatol. 2000 Jun;27(6):1390-4
pubmed: 10852259
Arthritis Care Res (Hoboken). 2019 Jul;71(7):949-960
pubmed: 30044541
Arthritis Rheum. 2001 Mar;44(3):662-5
pubmed: 11263781
Am J Ind Med. 2016 Sep;59(9):709-21
pubmed: 27582473
Curr Opin Toxicol. 2018 Aug;10:15-22
pubmed: 29503968
Nat Commun. 2019 Aug 29;10(1):3902
pubmed: 31467281
Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11685-8
pubmed: 15280534
Arthritis Rheum. 2004 Nov;50(11):3458-67
pubmed: 15529351
Arthritis Care Res (Hoboken). 2016 Mar;68(3):292-8
pubmed: 26239524
Environ Health Perspect. 2009 Jul;117(7):1065-9
pubmed: 19654914
Arthritis Rheum. 2002 Jul;46(7):1840-50
pubmed: 12124868
RMD Open. 2019 Jul 11;5(2):e000978
pubmed: 31413868
J Inflamm (Lond). 2015 Jul 30;12:48
pubmed: 26225124
J Am Acad Dermatol. 1990 Mar;22(3):444-8
pubmed: 2155953
J Rheumatol. 1996 Nov;23(11):1866-71
pubmed: 8923358
J Urban Health. 2008 Nov;85(6):880-909
pubmed: 18785012
Mediators Inflamm. 2015;2015:460310
pubmed: 25741130
Arthritis Rheumatol. 2017 Oct;69(10):2006-2017
pubmed: 28891252
Arthritis Rheum. 1998 Jun;41(6):1111-8
pubmed: 9627022
Arthritis Rheum. 2002 Jan;46(1):83-91
pubmed: 11817612
Ann Rheum Dis. 2005 Apr;64(4):582-6
pubmed: 15319232
Lupus. 2006;15(11):737-45
pubmed: 17153844
Biol Psychiatry. 2015 Feb 15;77(4):365-74
pubmed: 25104173
BMC Res Notes. 2015 Feb 15;8:42
pubmed: 25889176
Psychosom Med. 2010 Jun;72(5):481-6
pubmed: 20410244
J Immunol Res. 2014;2014:138751
pubmed: 24982919
Behav Res Ther. 1996 Aug;34(8):669-73
pubmed: 8870294
PLoS One. 2012;7(12):e51506
pubmed: 23284705
J Rheumatol. 1996 Nov;23(11):1862-5
pubmed: 8923357
Arthritis Rheum. 2013 Nov;65(11):2737-47
pubmed: 24122180
Lupus. 2005;14(10):832-6
pubmed: 16304727
Arthritis Rheum. 1997 Sep;40(9):1725
pubmed: 9324032
Arthritis Rheum. 2006 Nov;54(11):3648-54
pubmed: 17075811
Clin Immunol. 2018 Nov;196:21-33
pubmed: 29605707
Arthritis Rheumatol. 2015 May;67(5):1369-76
pubmed: 25779102
J Autoimmun. 2012 Dec;39(4):253-8
pubmed: 22771005
Am J Ind Med. 2011 Dec;54(12):897-905
pubmed: 21932428
Ann Rheum Dis. 2002 Jun;61(6):554-8
pubmed: 12006334
Ann Epidemiol. 1995 Jul;5(4):297-302
pubmed: 8520712
Arthritis Rheum. 2010 Sep;62(9):2569-81
pubmed: 20872595
N Engl J Med. 1975 Feb 20;292(8):403-7
pubmed: 1089199